Physician profile
Michael Brian Ellman
NPI 1336305952
$242,855.46
in general payments reported to CMS, 2019-2025
8 companies · $51K in 2025
The $51K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $20K · 2021: $40K · 2022: $17K · 2023: $41K · 2024: $44K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $100K · Royalty Or License: $27K · Travel and Lodging: $6,122 · Food and Beverage: $2,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $100,350.00 |
| Royalty Or License | $27,182.53 |
| Travel and Lodging | $6,122.32 |
| Food and Beverage | $2,260.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $240,796.03 | 2019-2025 | Insignia, Iconix, Knotilus Anchor, 3.5mm |
| Gemini Mountain Medical, LLC | $1,016.39 | 2019-2024 | |
| Smith+Nephew, INC. | $537.73 | 2019 | |
| Zimmer Biomet Holdings, INC. | $273.07 | 2021-2023 | Tapestry |
| Pacira Pharmaceuticals Incorporated | $124.22 | 2022 | |
| Vericel Corporation | $49.07 | 2023 | Maci |
| Depuy Synthes Sales INC. | $34.95 | 2023 | Na |
| Avanos Medical | $24.00 | 2025 | Grpro 2.1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.